{"result":[{"researchInterest":"Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6097&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Michael_Amylon","appointments":[{"appointment":"Emeritus (Active) Professor,Pediatrics - Stem Cell Transplantation"}],"clinicalFocus":[{"focus":"Pediatric Hematology-Oncology"},{"focus":"Ped Hematology/Oncology"}],"firstName":"Michael","primaryAppointment":"Emeritus (Active) Professor,Pediatrics - Stem Cell Transplantation","displayName":"Michael Amylon","lastName":"Amylon"},{"researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3925&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Daniel_Arber","appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"firstName":"Daniel","primaryAppointment":"Professor - Med Center Line,Pathology","displayName":"Daniel A. Arber, M.D.","lastName":"Arber"},{"researchInterest":"Germ cell tumors and bone sarcomas.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4473&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Neyssa_Marina","appointments":[{"appointment":"Professor - Med Center Line,Pediatrics - Hematology/Oncology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"firstName":"Neyssa","primaryAppointment":"Professor - Med Center Line,Pediatrics - Hematology/Oncology","displayName":"Neyssa Marina","lastName":"Marina"},{"researchInterest":"The role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4506&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Michael_Cleary","appointments":[{"appointment":"Professor,Pathology"},{"appointment":"Member,Cancer Center"},{"appointment":"Professor,Pediatrics"}],"clinicalFocus":[],"firstName":"Michael","primaryAppointment":"Professor,Pathology","displayName":"Michael Cleary","lastName":"Cleary"},{"researchInterest":"The research in my laboratory involves the application of monoclonal and polyclonal antibodies and a variety of immunohistochemical methods to study human B-cell, T-cell, accessory cell and related neoplasms.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3786&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Roger_Warnke","appointments":[{"appointment":"Professor,Pathology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"firstName":"Roger","primaryAppointment":"Professor,Pathology","displayName":"Roger Warnke","lastName":"Warnke"},{"researchInterest":"My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5929&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Yasodha_Natkunam","appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Hematopathology"},{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"firstName":"Yasodha","primaryAppointment":"Associate Professor - Med Center Line,Pathology","displayName":"Yasodha Natkunam, M.D., Ph.D","lastName":"Natkunam"},{"researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4608&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Ronald_Levy","appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"}],"firstName":"Ronald","primaryAppointment":"Professor,Medicine - Oncology","displayName":"Ronald Levy, MD","lastName":"Levy"},{"researchInterest":"Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphoma. Research Interests: clinical trials in Hodgkin's disease and malignant lymphoma including high dose therapy and autografting, complications of cytotoxic therapy, novel therapeutics, and clinicopathologic correlations.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4106&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Sandra_Horning","appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Oncology"}],"clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease - Blood and Marrow Transplant"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Leptommeningeal Disease"},{"focus":"Leptommeningeal Disease - Medical Oncology"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Blood and Marrow Transplant"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"}],"firstName":"Sandra","primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Oncology","displayName":"Sandra Horning","lastName":"Horning"},{"researchInterest":"Our labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4138&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Robert_Negrin","appointments":[{"appointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"firstName":"Robert","primaryAppointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","displayName":"Robert Negrin","lastName":"Negrin"},{"researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Matt_Van de Rijn","appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"firstName":"Matt","primaryAppointment":"Professor - Med Center Line,Pathology","displayName":"Matt Van de Rijn","lastName":"Van de Rijn"},{"researchInterest":"Functional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models: Williams-Beuren syndrome, a heterozygous 1.6 megabase deletion; Rett syndrome, caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene. Mechanisms of genomic imprinting: Prader Willi syndrome","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4281&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Uta_Francke","appointments":[{"appointment":"Professor,Genetics"},{"appointment":"Professor,Pediatrics"}],"clinicalFocus":[{"focus":"Clinical Genetics"},{"focus":"Neurogenetics"}],"firstName":"Uta","primaryAppointment":"Professor,Genetics","displayName":"Uta Francke","lastName":"Francke"},{"researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Ranjana_Advani","appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "}],"firstName":"Ranjana","primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","displayName":"Ranjana Advani","lastName":"Advani"},{"researchInterest":"Dr. Michael F. Clarke is the Associate Director of the Stanford Institute for Stem Cell and Regenerative Medicine.  In addition to his clinical duties in the division of Oncology, Dr. Clarke maintains a laboratory  focused on two areas of research: i) the control of self-renewal of normal stem cells and their malignant counterparts; and ii) the identification and characterization of cancer stem cells. A central issue in stem cell biology is to understand the mechanisms that regulate self-renewa","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7126&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Michael_Clarke","appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Colorectal Cancer"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"}],"firstName":"Michael","primaryAppointment":"Professor,Medicine - Oncology","displayName":"Michael F. Clarke, M.D.","lastName":"Clarke"},{"researchInterest":"","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6365&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Ronald_Dorfman","appointments":[{"appointment":"Emeritus Faculty, Acad Council,Pathology"}],"clinicalFocus":[],"firstName":"Ronald","primaryAppointment":"Emeritus Faculty, Acad Council,Pathology","displayName":"Ronald Dorfman","lastName":"Dorfman"},{"researchInterest":"Stem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4605&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Irving_Weissman","appointments":[{"appointment":"Professor,Pathology - Stem Cell Institute"},{"appointment":"Professor,Developmental Biology"},{"appointment":"Professor (By courtesy),Biology (School of Humanities and Sciences)"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[],"firstName":"Irving","primaryAppointment":"Professor,Pathology - Stem Cell Institute","displayName":"Irving Weissman","lastName":"Weissman"},{"researchInterest":"I work as a diagnostic surgical pathologist doing tissue and cDNA microarray-based translational research in renal neoplasia and medical renal disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4038&type=small&showNoImage","href":"http://med.stanford.edu/profiles/John_Higgins","appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"firstName":"John","primaryAppointment":"Associate Professor - Med Center Line,Pathology","displayName":"John Higgins","lastName":"Higgins"},{"researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4131&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Branimir_Sikic","appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"firstName":"Branimir","primaryAppointment":"Professor,Medicine - Oncology","displayName":"Branimir I. Sikic, M. D.","lastName":"Sikic"},{"researchInterest":"My recent research efforts are currently focused in the field of applications of immunohistology to the diagnosis of human neoplasms. This work is predominantly aimed at characterizing markers for the identification of non-lymphoid neoplasms and at establishing criteria for their evaluation in diagnostic situations.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4491&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Robert_Rouse","appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"firstName":"Robert","primaryAppointment":"Professor - Med Center Line,Pathology","displayName":"Robert V Rouse","lastName":"Rouse"},{"researchInterest":"Our laboratory focuses on translational research in 2 main areas - molecular testing for patients with hematolymphoid malignancy and disorders of thrombosis and hemostasis.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4024&type=small&showNoImage","href":"http://med.stanford.edu/profiles/James_Zehnder","appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Hematology"},{"focus":"Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"firstName":"James","primaryAppointment":"Professor - Med Center Line,Pathology","displayName":"James L. Zehnder, M.D.","lastName":"Zehnder"},{"researchInterest":"Combined Modality Treatment of Cancer\r\nLate Effects of Treatment\r\nGenetic Effects of Cancer\r\nRhabdomyosarcoma\r\nHodgkins Disease\r\nPediatric Radiation Oncolgy\r\nPediatric Oncolgy\r\nBreast Cancer\r\nConformal Radiotherapy/IMRT\r\nRadiotherapy for Benign Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4098&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Sarah_Donaldson","appointments":[{"appointment":"Professor,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Basal / Squamous Cell Carcinomas - Radiation Oncology"},{"focus":"Bone Cancer"},{"focus":"Brain / Central Nervous System Tumors"},{"focus":"Brain / Central Nervous System Tumors - Radiation Oncology"},{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Radiation Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Radiation Oncology"},{"focus":"Childhood Cancers"},{"focus":"Eye / Orbital Cancer"},{"focus":"Eye / Orbital Cancer - Benign"},{"focus":"Eye / Orbital Cancer - Malignancies"},{"focus":"Germ Cell Tumors"},{"focus":"Germ Cell Tumors - Radiation Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Radiation Oncology"},{"focus":"Leukemia"},{"focus":"Leukemia - Radiation Oncology"},{"focus":"Lymphoma "},{"focus":"Melanoma"},{"focus":"Melanoma - Radiation Oncology"},{"focus":"Multiple Myeloma"},{"focus":"Multiple Myeloma - Radiation Oncology"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Radiation Oncology"},{"focus":"Osteosarcoma "},{"focus":"Pediatric Cancers"},{"focus":"Pigmented Skin Lesions"},{"focus":"Pigmented Skin Lesions - Radiation Oncology"},{"focus":"Pituitary Adenomas"},{"focus":"Pituitary Adenomas - Radiation Oncology"},{"focus":"Radiation Oncology"},{"focus":"Sarcomas - Bone "},{"focus":"Sarcomas - Bone - Radiation Oncology"},{"focus":"Sarcomas - Radiation Oncology"},{"focus":"Sarcomas - Soft Tissue "},{"focus":"Sarcomas - Soft Tissue - Radiation Oncology"},{"focus":"Skin Cancer "},{"focus":"Skin Cancer - Radiation Oncology"},{"focus":"Therapeutic Radiology"},{"focus":"Thyroid Cancers"},{"focus":"Thyroid Cancers - Radiation Oncology  "}],"firstName":"Sarah","primaryAppointment":"Professor,Radiation Oncology - Radiation Therapy","displayName":"Sarah S. Donaldson, M.D.","lastName":"Donaldson"},{"researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9558&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Arash_Alizadeh","appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"clinicalFocus":[],"firstName":"Arash","primaryAppointment":"Instructor,Medicine - Oncology","displayName":"Ash A. Alizadeh, MD/PhD","lastName":"Alizadeh"},{"researchInterest":"Allogeneic and autologous bone marrow transplantation (experimental and clinical) as a treatment modality for leukemia, lymphoma, Hodgkin's disease, multiple myeloma, hereditary disorders, immune defects and selective solid tumors. Development of novel preparatory regimens to prevent the recurrence of the underlying malignancies. Studies for the prevention of acute and chronic graft-versus-host disease. Testing of new anti-viral agents to prevent or treat viral infections.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4180&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Karl_Blume","appointments":[{"appointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[],"firstName":"Karl","primaryAppointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","displayName":"Karl Blume","lastName":"Blume"},{"researchInterest":"Pediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5921&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Norman_Lacayo","appointments":[{"appointment":"Assistant Professor - Med Center Line,Pediatrics - Hematology/Oncology"}],"clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"firstName":"Norman","primaryAppointment":"Assistant Professor - Med Center Line,Pediatrics - Hematology/Oncology","displayName":"Norman J. Lacayo, MD","lastName":"Lacayo"},{"researchInterest":"As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4109&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Phyllis_Cornbleet","appointments":[{"appointment":"Emeritus (Active) Associate Professor,Pathology"}],"clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"firstName":"Phyllis","primaryAppointment":"Emeritus (Active) Associate Professor,Pathology","displayName":"Phyllis Cornbleet","lastName":"Cornbleet"},{"researchInterest":"Non-Hodgkin's Lymphoma;\r\nSoft tissue sarcoma;\r\nOsteosarcoma.","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6696&type=small&showNoImage","href":"http://med.stanford.edu/profiles/Kristen_Ganjoo","appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"clinicalFocus":[{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Lymphoma "},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Sarcomas - Soft Tissue "}],"firstName":"Kristen","primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","displayName":"Kristen Ganjoo","lastName":"Ganjoo"}]}